Navigation Links
Special chip provides better picture of salmon health

How do you tell if a fish is fit and well? This is a question which has troubled farmers and biologists for years, but now scientists may have come up with the answer - using DNA chips. By studying the genes of Atlantic salmon scientists from three UK universities are developing a DNA chip to monitor the health and performance of salmon, a tool which could both save the salmon industry thousands and also help conserve dwindling wild salmon populations.

Atlantic salmon are the most important farmed fish in the UK and a disappearing species in the wild. They are particularly vulnerable to infection because of the dramatic physical and chemical changes they go through, known as smoltification, which enable them to live in both fresh and salt water. Assessing their health and performance is very difficult as conventional measures used in other animals, such as temperature, blood protein levels and general demeanour, are not relevant or are difficult to assess in fish.

Farmers and conservationists currently have to rely on the general appearance of salmon as an indicator of their health, which is far from ideal. The new DNA chip will help farmers assess the state of their stock more accurately and also enable conservationists to sample wild populations to ascertain their health and wellbeing.

The development of the chip is the culmination of a four-year study known as Salmon TRAITS (Transcription Analysis of Important Traits in Salmon) being carried out by scientists at the Universities of Stirling, Aberdeen and Cardiff, together with ARK Genomics at the Roslin Institute and researchers at the Norwegian School of Veterinary Science. Funding for the project is from the Biotechnology and Biological Sciences Research Council's (BBSRC) Exploiting Genomics initiative.

To develop a more effective method of monitoring salmon health and performance the scientists have been studying salmon gene expression. By doing this, they have identified
'"/>

Source:Biotechnology and Biological Sciences Research Council


Page: 1 2 3

Related biology news :

1. Special Imaging Study Shows Failing Hearts Are Energy Starved
2. Specialized immune-system B cells play double-barreled role
3. Biologists Crack Genetic Code for Specialized Spider Silk
4. MetaChip provides quick, efficient toxicity screening of potential drugs
5. NYU and MSKCC research provides model for understanding chemically induced cancer initiation
6. Nature provides inspiration for important new adhesive
7. New plant DNA libraries provides massive boost to worlds plant researchers
8. NASA satellite data provides rapid analysis of Amazon deforestation
9. Study provides insight into cellular defenses against genetic mutation
10. Customized gene chip provides rapid detection of genetic changes in childrens cancer
11. Vaccine provides 100 percent protection against avian flu virus in animal study
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Special chip provides better picture salmon health

(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new ... fully hardware encapsulated fingerprint sensor and matching ... is literally off the grid, isolating fingerprint ... within the fingerprint sensor to provide ultimate ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... heart attack, the portions of the heart damaged by a ... ways to avoid this scarring, which can harden the walls ... the body and eventually lead to heart failure. But new ... School of Medicine shows that interrupting this process can weaken ...
... 2011, Stephen Boppart from the University of Illinois ... convened by the Optical Society of America (OSA). The ... Advisory Committee for the Congressional Research and Development Caucus. ... and of bioengineering at Illinois, will be the first ...
... Nairobi, 15 November 2011 Farmer trainers should be ... rather than on their successes in implementing farming techniques, shows ... the World Agroforestry Centre (ICRAF). , In the study by ... shrubs, fast-growing leguminous shrubs for feeding dairy cows, in Kenya ...
Cached Biology News:Scarring a necessary evil to prevent further damage after heart attack 2Boppart presents at Congressional briefing 2Teaching skills key to selection of a successful model farmer 2
(Date:7/29/2015)...  HealthSouth Corporation (NYSE: HLS ), one ... services, offering both facility-based and home-based post-acute services, ... second quarter ended June 30, 2015. ... growth in both segments and an 11.0% increase ... and Chief Executive Officer of HealthSouth. "While reported ...
(Date:7/29/2015)... Inc., an early stage biotech startup based on perinatal ... the Musculoskeletal Transplant Foundation of Edison NJ ... round of development of the proprietary AmnioCept™ product line ... AmnioChor,s technology allows cryopreservation of the amniotic membrane of ... those tissues. Amnion is a well-established source of multipotent ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company, is pleased to announce that the final design ... been locked.  Prototypes for industrial and regulatory testing ... application for CE mark clearance to market the ... 2016. (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  ...
(Date:7/29/2015)... ... 2015 , ... Costello served as Lead Levee Design Engineering Manager for a ... Texas area from future storm surge flooding, such as occurred in Hurricane Ike in ... alternatives for providing protection, Costello also balanced socio-economic and environmental needs and ...
Breaking Biology Technology:HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27HealthSouth Reports Results for Second Quarter 2015 28HealthSouth Reports Results for Second Quarter 2015 29HealthSouth Reports Results for Second Quarter 2015 30HealthSouth Reports Results for Second Quarter 2015 31HealthSouth Reports Results for Second Quarter 2015 32HealthSouth Reports Results for Second Quarter 2015 33HealthSouth Reports Results for Second Quarter 2015 34HealthSouth Reports Results for Second Quarter 2015 35HealthSouth Reports Results for Second Quarter 2015 36
... Majority of Physicians are Most Concerned About Lack of Reimbursement ... from ... Decision Resources, ... leading research and advisory firms for pharmaceutical and,healthcare issues, finds ...
... Wall Street Journal published,an article on October 29th ... Group LLC and featuring quotes from,President and founder ... Use of Transfusions: New Efforts to Recycle Blood ... Risks, is part of the "The Informed Patient",series ...
... 3 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ... on,endocrine therapy and oncology, today reported that it ... its Phase 2 trial in endometrial,cancer with AEZS-108, ... The decision to enter the second stage of,patient ...
Cached Biology Technology:The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use 2The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use 3Wall Street Journal Highlights Blood Management, Strategic Healthcare Group LLC, and Dr. Timothy Hannon 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5
... Adding an exciting new chapter ... GC leadership, Agilents 7890A GC ... to take your lab to ... and GC/MS performance, including advanced ...
... Pan-Caspase In Situ Assay Kit, Fluorescein is ... caspases in cells undergoing apoptosis. The kit ... use in diagnostic or therapeutic procedures. CHEMICON®s ... a novel approach to detect active caspases. ...
... concentrated jetSI 10 nM is available for ... brain as described in: Z. Hassani, G.-F. ... J.-P. Behr, and B.-A. Demeneix. Lipid-mediated siRNA ... the mouse brain at picomolar levels. J. ...
... Tissue Staining Kits are intended for localization ... histological and cytological specimens. These kits may ... by either R&D Systems or by other ... formation of the Avidin-Biotin Complex (ABC) with ...
Biology Products: